Orbimed Advisors - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 123 filers reported holding PULMONX CORP in Q3 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of PULMONX CORP
ValueSharesWeighting
Q3 2022$7,247,000
+13.2%
435,0000.0%0.14%
+16.4%
Q2 2022$6,403,000
-40.7%
435,0000.0%0.12%
-33.7%
Q1 2022$10,792,000
-22.6%
435,0000.0%0.18%
-2.2%
Q4 2021$13,950,000
-10.9%
435,0000.0%0.18%
+4.1%
Q3 2021$15,651,000
+183.8%
435,000
+248.0%
0.17%
+207.1%
Q2 2021$5,515,000
-3.6%
125,0000.0%0.06%
+5.7%
Q1 2021$5,718,000
-33.7%
125,0000.0%0.05%
-29.3%
Q4 2020$8,628,000125,0000.08%
Other shareholders
PULMONX CORP shareholders Q3 2021
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 60,204$1,494,00012.13%
Miura Global Management 595,000$14,762,0004.80%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,695,341$91,681,0002.05%
Millrace Asset Group, Inc. 78,859$1,956,0001.42%
NEXT CENTURY GROWTH INVESTORS LLC 436,034$10,818,0001.08%
Novo Holdings A/S 410,155$10,176,0000.54%
PURA VIDA INVESTMENTS, LLC 589,722$14,631,0000.47%
Rock Springs Capital Management LP 702,400$17,427,0000.44%
RTW INVESTMENTS, LP 798,255$19,805,0000.41%
Regis Management CO LLC 82,070$2,036,0000.36%
View complete list of PULMONX CORP shareholders